Evidence map›Paper›PMID 22532325›Full record

ArticleInternational journal of cancer2012

Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: phenotypic differences between transformed and nontransformed stem cells.

Shubhashish Sarkar, Carla Kantara, Ixiu Ortiz, Rafal Swiercz, Joyce Kuo, Robert Davey, Kenneth Escobar, Robert Ullrich, Pomila Singh

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Relationship betweenWorld journal of gastrointestinal surgery · 2024
    Article
  2. Isolating Circulating Cancer Stem Cells (CCSCs) from Human Whole Blood.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Epigenetic regulation of humanStem cell investigation · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Novel roles of gastrin.The Journal of physiology · 2014
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shubhashish SarkarDepartment of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX 77555-1043, USA.
Carla Kantara
Ixiu Ortiz
Rafal Swiercz
Joyce Kuo
Robert Davey
Kenneth Escobar
Robert Ullrich
Pomila Singh
The University of Texas Medical Branch at Galveston · USJohn Sealy Hospital · US

Funding

Role of Annexin-II in growth factor/co-carcinogenic effects of progastrinR01CA097959 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SINGH, POMILA · 2003 to 2015
$3.7M
Growth Factors, Curcumin and Colon CarcinogenesisR01CA114264 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SINGH, POMILA · 2006 to 2010
$1.3M
NCI NIH HHS CA114264NCI NIH HHS CA97959NCI NIH HHS R01 CA097959NCI NIH HHS R01 CA114264
6 · The paper itself

Abstract

We recently reported that overexpression of progastrin (PG) in embryonic epithelial cells (HEKmGAS cells) increased proliferation of the cells compared to that of control HEKC cells. Here, we report the novel finding that tumorigenic and metastatic potential of HEKmGAS cells is also increased significantly compared to that of HEKC cells. Cell surface-associated annexinA2 (CS-ANXA2) binds PG and is overexpressed on cancer cells, allowing us to successfully use fluorescently labeled PG peptide for enumerating metastatic lesions of transformed/cancer cells in vivo. Next, we examined the hypothesis that increased tumorigenic/metastatic potential of isogenic HEKmGAS versus HEKC cells maybe due to transformed phenotype of stem cells. FACSorting/FACScanning of cells demonstrated significant increases in percent doublecortin-CAM-kinase-like1 (DCLK1)/Lgr5-positive stem cells, coexpressing cluster of differentiation44 (CD44)/CS-ANXA2, in HEKmGAS versus HEKC cells. Distinct differences were noted in the morphology of HEKC versus HEKmGAS spheroidal growths on nonadherent cultures (selective for stem cells). HEKC spheroids were rounded with distinct perimeters (e.g., basement membranes), whereas HEKmGAS spheroids were amorphous with no perimeters. Relative levels of DCLK1/Lgr5/CD44 and ANXA2/β-catenin/pNFκBp65/metalloproteinases were significantly increased in HEKmGAS versus HEKC cells, growing as monolayer cultures, 3D spheroids (in vitro), or xenografts (in vivo). Interestingly, HEKC cells enriched for CS-ANXA2 developed amorphous spheroids, whereas downregulation of ANXA2 in HEKmGAS clones resulted in loss of matrixmetalloproteinases (MMPs) and re-formation of rounded spheroids, suggesting that high levels of CS-ANXA2/MMPs may impact spheroid morphology. Downregulation of DCLK1 significantly attenuated activation of β-catenin, with loss of proliferation of HEKmGAS and HEKC cells, suggesting that DCLK1 is required for maintaining proliferation of cells. Our results suggest the novel possibility that transformed stem cells, unlike nontransformed stem cells, coexpress stem cell markers DCLK1 and CD44 with CS-ANXA2.

Indexed as

Gene ExpressionPhenotypeAnimalsAnnexin A2beta CateninBiomarkersCell LineCell Transformation, NeoplasticDoublecortin-Like KinasesEpithelial CellsGastrinsGene Expression RegulationHumansHyaluronan ReceptorsIntracellular Signaling Peptides and ProteinsMembrane ProteinsAnnexin A2beta Cateninbig gastrinBiomarkersDCLK1 protein, humanDoublecortin-Like KinasesGastrinsHyaluronan ReceptorsIntracellular Signaling Peptides and ProteinsMembrane ProteinsProtein PrecursorsProtein Serine-Threonine Kinases

Identifiers

PMID22532325
PMCPMC3409332
OpenAlexW1991949875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.